Danaher

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Danaher and other ETFs, options, and stocks.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions.

CEO

Rainer M. Blair

CEORainer M. Blair

Employees

63,000

Employees63,000

Headquarters

Washington, District of Columbia

HeadquartersWashington, District of Columbia

Founded

1984

Founded1984

Employees

63,000

Employees63,000

DHR Key Statistics

Market cap

197.85B

Market cap197.85B

Price-Earnings ratio

47.93

Price-Earnings ratio47.93

Dividend yield

0.39%

Dividend yield0.39%

Average volume

3.76M

Average volume3.76M

High today

$277.72

High today$277.72

Low today

$271.38

Low today$271.38

Open price

$271.38

Open price$271.38

Volume

2.80M

Volume2.80M

52 Week high

$277.72

52 Week high$277.72

52 Week low

$182.09

52 Week low$182.09

DHR News

Yahoo Finance 5h

Danaher Corporation: Hedge Funds Are Bullish on This Scientific Instruments Stock Right Now - Yahoo Finance

...

Reuters 3d

Q2 2024 Danaher Corp Earnings Call

Participants John Bedford; Vice President - Investor Relations; Danaher Corp Rainer Blair; President, Chief Executive Officer, Director; Danaher Corp Matthew...

CNBC 3d

We're raising our price target on Danaher stock as it sheds a major overhang

Shares of Danaher popped more than 6% on Tuesday after the life sciences company delivered a strong quarter and reaffirmed its guidance — signaling the longtime...

Analyst ratings

69%

of 26 ratings

Buy

69.2%

Hold

30.8%

Sell

More DHR News

Barron's 4d

Danaher Stock Is Surging. Strong Earnings Renew Hopes for Recovery.

Danaher stock jumped 7% early Tuesday, amid optimism for shares that have stagnated in recent years. Danaher which sells tools and services for drug developers...

Investor's Business Daily 4d

Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival

Danaher (DHR) stock flirted with a breakout Tuesday on the back of its unexpectedly strong sales from its molecular testing services. The company's molecular t...

Benzinga 4d

Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance

On Tuesday, Danaher Corp's DHR second quarter sales decreased 3% year-over-year to $$5.743 billion, beating the consensus of $5.59 billion. Non-GAAP core reven...

Barron's 4d

Danaher Stock Surges. More Than Earnings Are Driving It Higher.

Danaher stock was rising sharply Tuesday after the medical company reported better-than-expected second-quarter earnings and revenue. Danaher posted second-quar...

Seeking Alpha 4d

Danaher gains as biotech and diagnostics drive Q2 beat

Danaher Corporation (NYSE:DHR) traded higher premarket Tuesday after the Washington, DC-based healthcare giant exceeded Street forecasts with its Q2 2024 result...